When was Amplified Sciences founded?

Amplified Sciences was founded in 2016 and raised its 1st funding round 4 years after it was founded.

Where is Amplified Sciences located?

Amplified Sciences is headquartered in West Lafayette, United States.

How many employees does Amplified Sciences have?

As of Aug 31, 2026, the latest employee count at Amplified Sciences is 14.

Is Amplified Sciences a funded company?

Amplified Sciences is a funded company, having raised a total of $8.62M across 11 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Apr 24, 2020.

When was the latest funding round of Amplified Sciences?

Amplified Sciences' latest funding was a $***** Seed round on Jun 04, 2026, with participation from 2 investors. Its primary sector is Oncology. In United States, the Oncology sector has seen $6.51B in funding in 2026 to date.

Where does Amplified Sciences rank among its competitors?

Amplified Sciences ranks 1st amongst 17 active competitors, of which 5 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Amplified Sciences, which secured an undisclosed amount in Jun, 2026.

Who are the top competitors of Amplified Sciences?

Amplified Sciences' top competitors include Reccan Diagnostics, BiomaRx Therapeutics and Acobiom. Among them, Amplified Sciences secured the most recent funding round in June, 2026.

Amplified Sciences - 2026 Company Profile, Funding & Competitors

Company Details

Developer of in-vitro diagnostic test for the detection of debilitating diseases across oncology and chronic kidney disease. The company offers PanCystPro uses a proprietary platform to detect biomarker levels and activity in minute volumes of pancreatic cyst fluid for patients at higher risk for pancreatic cancer diagnosed with pancreatic cystic lesions.

Website: amplifiedsciences.com
Social

Key Metrics

Founded Year

2016

Location

West Lafayette, United States

Stage

Seed

Total Funding

$8.62M in 11 rounds

Latest Funding Round

Seed, Jun 04, 2026, $*****

Investors

OCA Ventures & 17 more

Ranked

1^st among 17 active competitors

Employee Count

14 as on Aug 31, 2026

Similar Companies

Reccan Diagnostics & 15 more

View Amplified Sciences' full profile

Amplified Sciences is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
AMPLIFIED SCIENCES, LLC CIN: 812008087 , United States, Active	Dec 31, 2015	-	9 (As on Dec 31, 2024)	-

Amplified Sciences has raised a total funding of $8.62M over 11 rounds. Its first funding round was on Apr 24, 2020. Its latest funding round was a Seed round on Jun 04, 2026 for $*****. 2 investors participated in its latest round. Amplified Sciences has 18 institutional investors.

Here is the list of recent funding rounds of Amplified Sciences:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 04, 2026	1248904	Seed	7920397	7953974	5692364	9649088
Aug 11, 2025	7370486	Seed	8466112	1424763	6848402	5857283
Mar 20, 2025	1133846	Grant (prize money)	9374367	7905571	3494752	HHS

Access funding benchmarks and valuations. Sign up today!

View details of Amplified Sciences's funding rounds and investors

Amplified Sciences' employee count trend

Amplified Sciences has 14 employees as of Aug 26. Here is Amplified Sciences's employee count trend over the years:

Employee count trend for Amplified Sciences

Uncover Amplified Sciences' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Amplified Sciences include Reccan Diagnostics, BiomaRx Therapeutics and Acobiom. Here is the list of Top 10 competitors of Amplified Sciences, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Amplified Sciences 2016, West Lafayette (United States), Seed	Developer of in-vitro diagnostic test for the detection of debilitating diseases across oncology and chronic kidney disease	$8.62M	IU Ventures, OCA Ventures & 16 others	54/100
2nd	Reccan Diagnostics 2015, Lund (Sweden), Seed	Provider of protein biomarkers based in vitro diagnostics for solid cancers	$1.54M	Cardeon, Faro Capital & 2 others	31/100
3rd	BiomaRx Therapeutics 2014, Cambridge (United States), Funding Raised	Provider of diagnostic and therapeutic tool for pancreatic cancer	-	Inctank Ventures	29/100
4th	Acobiom 1999, Grabels (France), Early Stage	Developer of diagnostics for personalized medicine applications and provided omics services	$1.29M	EIC Fund, Bpifrance & 2 others	29/100
5th	Ultrasonic Medical Mapping 2019, Bethesda (United States), Funding Raised	Developer of a diagnostic system for detecting pancreatic cancer	-	Goldfingr, Health Wildcatters	27/100
6th	Precision Panc 2017, Bearsden (United Kingdom), Unfunded	Developer of precision medicine for pancreatic cancer	-	-	25/100
7th	PancraGEN 2014, Pittsburgh (United States), Unfunded	Pathological testing tool for clinical	-	-	24/100
8th	PancreatRX 2013, Houston (United States), Unfunded	Develops cancer diagnostics and therapeutics	-	-	24/100
9th	RedVault Biosciences 2013, Houston (United States), Funding Raised	Innovating genomic medicine through technology to improve human health and well-being	-	HHS	24/100
10th	Cosomil 2022, Bunkyo (Japan), Series A	Developer of enzyme activity-based liquid biopsy test for the detection of cancer	-	Coral Capital, ANRI & 4 others	23/100